Free Chat Friday (Every Friday) -- Our live chat room with stock and option alerts! Fridays, starting at 9:30 am,
go to: http://getstockideas.webinato.com/room1 use the password: freechatfriday

Syros Pharmaceuticals, Inc.
(NASDAQ : SYRS)

( )
SYRS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.98%81.590.9%$637.74m
CELGCelgene Corporation
-0.88%135.961.1%$563.57m
AMGNAmgen Inc.
-1.16%184.121.1%$451.54m
BIIBBiogen Inc.
-0.63%342.421.2%$397.97m
REGNRegeneron Pharmaceuticals, Inc.
0.36%440.942.7%$313.46m
ALNYAlnylam Pharmaceuticals, Inc
-1.63%115.6310.7%$252.14m
VRTXVertex Pharmaceuticals Incorporated
-0.10%154.601.9%$218.27m
INCYIncyte Corporation
-0.76%114.272.5%$205.56m
ALXNAlexion Pharmaceuticals, Inc.
0.16%140.461.9%$180.37m
EXELExelixis, Inc.
-0.25%27.466.5%$136.95m
ILMNIllumina, Inc.
-0.21%205.183.5%$132.63m
BLUEBluebird Bio, Inc.
0.25%139.4517.3%$114.79m
BMRNBioMarin Pharmaceutical Inc.
-0.55%88.134.4%$113.12m
SRPTSarepta Therapeutics, Inc.
-1.36%50.7216.9%$105.98m
CLVSClovis Oncology, Inc.
-2.48%76.7716.5%$102.15m

Company Profile

Syros Pharmaceuticals, Inc. engages in the development of novel gene control therapies for cancer and other diseases. It has developed a proprietary platform that is designed to systematically and efficiently analyze unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations. The company focuses on developing treatments for cancer and immune mediated diseases and is building a pipeline of gene control medicines. Syros Pharmaceuticals was founded by Richard A. Young, Nathanael S. Gray and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.